Vaxxinity Inc. (VAXX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Vaxxinity Inc.

OTC: VAXX · Real-Time Price · USD
0.05
0.02 (99.60%)
At close: Mar 26, 2025, 2:50 PM

Vaxxinity Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-56.93M -75.22M -137.18M
Depreciation & Amortization
2.23M 1.68M 1.1M
Stock-Based Compensation
7.51K 8.71M 30.41M
Other Working Capital
-5.03M 7.72M 2.25M
Other Non-Cash Items
6M -926K 3.21M
Deferred Income Tax
n/a n/a 8.58M
Change in Working Capital
-8.54M 9.82M 12.88M
Operating Cash Flow
-57.24M -55.93M -80.99M
Capital Expenditures
-803K -1.87M -1.32M
Cash Acquisitions
n/a 52.53M n/a
Purchase of Investments
-63.94M -107.53M n/a
Sales Maturities Of Investments
93.59M 55M n/a
Other Investing Acitivies
n/a -52.53M n/a
Investing Cash Flow
28.84M -54.39M -1.32M
Debt Repayment
-1.59M -430K -771K
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
454K 263K 3.07M
Financial Cash Flow
-1.14M -167K 196.17M
Net Cash Flow
-29.53M -110.49M 113.86M
Free Cash Flow
-58.04M -57.79M -82.31M